Therefore, decreased transendothelial apoE4-Aβ clearance might explain, at least partly, the association between the ε4 allele, cerebral amyloid angiopathy, and Alzheimer’s disease, in individuals with an ABCA1 loss of function mutation [74]. Here, APOE is linked to Alzheimer disease.